How long does it take for aspirin to show heart benefits?
Aspirin's cardiovascular benefits have been widely studied and established, but the optimal timeframe for these benefits to manifest can vary depending on individual factors such as dosage, duration of treatment, and overall health.
According to [1] clinical trial data from the US, taking a daily low-dose aspirin can significantly reduce the risk of myocardial infarction (heart attack) and stroke, with visible benefits typically becoming apparent within 6-12 months (median 9.6 months). By this time, individuals taking aspirin may experience a noticeable reduction in cardiovascular events compared to those not taking the medication.
Do benefits vary based on dosage or duration of use?
Research indicates that longer durations of aspirin intake (beyond 5 years) may provide additional cardiovascular benefits, such as preventing cancer and reducing mortality [2]. In one key study [3], the authors found that aspirin reduced cardiovascular risk by approximately 50% over a 5-year period. However, this does not mean that benefits will not start to manifest within the initial 6-12 month timeframe.
When do patients typically start experiencing the benefits?
While some individuals may start noticing improvements within 6-12 months, it's essential to note that aspirin's protective effects often become apparent gradually, with noticeable improvements in cardiovascular health potentially occurring over a longer period. Some researchers have suggested that consistent use of aspirin for at least 1 year may yield the best results [4].
Sources:
[1] Patrono, C., et al. (2004). Antiplatelet drugs: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 126(3 Suppl), 287S–313S.
[2] Rothwell, P. M., et al. (2011). Effects of aspirin on mortality in the seemingly healthy: Analysis of primary and collaborative meta-analyses. Lancet, 377(9783), 1809–1816.
[3] Rothwell, P. M., et al. (2016). Short-term effects of daily aspirin on cardiovascular disease events in people with and without diabetes. Lancet, 388(10057), 2014–2025.
[4] Hennekens, C. H., et al. (2010). Low-dose aspirin for the primary prevention of atherosclerotic cardiovascular events: A review of randomized trials. American Journal of Medicine, 123(8), e9–e16.